Capital Flow Monitor · Sponsors · CIK 2046762
Tasca Therapeutics Corp
55 SPINELLI PLACE, CAMBRIDGE, MA, 02138 · 617-390-4306
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$70.2M
Sold
$48.1M
% sold
68.5%
Investors
9
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-01 | D/A ·current | 506(b) | $70.2M | $48.1M | 68.5% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Milenko Cicmil — Executive Officer / Director, Cambridge, MA
- Drew King — Executive Officer, Cambridge, MA
- Xu Wu — Director, Cambridge, MA
-
David Fallace — Director, Cambridge, MA
1 other raise
- Cure Ventures Fund II, L.P. $0 of —
- Michael Aberman — Director, Cambridge, MA
-
Praveen Tipirneni — Director, Cambridge, MA
1 other raise
- Caldera Therapeutics, Inc. $37.5M of $37.5M · 100.0%
- Seth Lieblich — Director, Cambridge, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.